RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group
Hirozumi Sano(Gunma Children's Medical Center), Yasuhide Hayashi(Gunma Children's Medical Center), Manabu Sotomatsu(Gunma Children's Medical Center), Ryōji Kobayashi(Kagawa University), Ryoji Hanada(Saitama Children's Medical Center), Akira Shimada(Tohoku University), Ichiro Tsukimoto(Toho University), Akio Tawa(Erasmus MC), Masahiro Tsuchida, Ken Tabuchi, Tomohiko Taki(Kyorin University), Chisato Murata(Gunma Children's Medical Center), Myoung-ja Park(Gunma Children's Medical Center), Keizo Horibe(National Hospital Organization)
Cited by 40
Related Papers
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Pharmacology of Protein Kinase Inhibitors
|The Annual Review of Pharmacology and Toxicology|1992|366
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation
|Blood|2017|352
Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System
|International Journal of Hematology|2007|345
Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2012|296